Research site

Poitiers, Vienne 86021

1 studies enrolling now · 3 studies all time

What they study most

Hypophosphatasia (HPP), Lymphoma, Follicular, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Plegridy Observational Program — Completed
• A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma — Completed